Collin F. Regan

7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity

Fabrice Pierre, Eric Stefan, Anne-Sophie Nédellec et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +11

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells

Fabrice Pierre, Collin F. Regan, Marie-Claire Chevrel et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · Full text

Antiproliferative Activity, Medicine, Receptor Tyrosine Kinase +7

<i>Se</i>‐Phenyl Prop‐2‐eneselenoate: An Ethylene Equivalent for Diels–Alder Reactions

Michael E. Jung, Felix Perez, Collin F. Regan et al. · Angewandte Chemie International Edition · 2013 · 25 citations

Engineering, Macromolecular Engineering, Many Dienes 1 +9

Potent, Orally Active Corticotropin-Releasing Factor Receptor-1 Antagonists Containing a Tricyclic Pyrrolopyridine or Pyrazolopyridine Core

Brian Dyck, Dimitri E. Grigoriadis, Raymond S. Gross et al. · Journal of Medicinal Chemistry · 2005 · 24 citations · Full text

Synthesis and SAR of inhibitors of protein kinase CK2: Novel tricyclic quinoline analogs

Mustapha Haddach, Fabrice Pierre, Collin F. Regan et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 16 citations · Full text

Medicinal Chemistry, Biochemistry, Protein Kinase Ck2 +7